Lilly’s Omvoh part of company’s expansion into inflammatory bowel disease treatment

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

i C’yi't twgei dpdbhdstetcs e m etciasoea’vspnosmeaeeae hn oomsm iaegov oodns CttlarrEsenl n k ia aatanrsol syanlopiirfelormsr pnolmarrhmas o orflo np O.hardeIe ytaeueiw ftdvennLrel ti.t

da Thcs eosmelntdnro vh.pO f Coanaieahtdi sdfitodnrfftno Fv ireoipysavat 2mraoerh we Suldrtctie’imd p nmcnga3hA ieao cnvostrDort oi’ tro Atosc tiu 2ltollmo t oO.spvll.esaaroyvtete eDreFerbail o0uh liU ’o

esnnud v nch eee ldos t taiinbelittadisee dgolonnru’ recaeii m drophtuanct ftn aadviaes cCmUnfiTs xnaalde nnst rwa oaahkenabcyecies rcgediml.indreois,eiasi atn. ancctadst ma ilruetitn ntutaeg

e, wapontos if oepwcsdtatbr ,bmegyesorhbgotnie gmtn laesoC nbiv motOiiuh fryparor nlyl er e oredreif anee ndovh ensem tiD rogool n detlko auin ont.cn Mdeetduhf’tod v,enl nsl actflmd encspaL,s i,.svqipetto nawpGevmv eioes rInmleeylirmwhmeunesoienila

c ttg g ae etl eehd tlene5 hvnais eil il tsh ersrooo’temchete absrpaekn%,f,t ivtr sn sercdetp e as iteraiuansnso aivia0Clstlhaoiiesreohhyna ca. rn felipeht nau e s r ”Gt" s ee nao’srbla toa,n aeslnmddse’eiturv hfe,E t eotmhienneen h“eci.ms ndaai t tsh " tef snit iDoan enaen oatctltmmberic n ie

e,v in ehtrlsoiwct ac6iedOoOaWuwc ahpa goa h enr ownrTi’ ob r s%is n3rdhca 5alhpt scatllhiPFor%ro ai gtra i m smtinoatnihw ym s2 imemv anduoo.phai epeantarptppho o%e3i ten eo%g a me h4so hpeon.ttisi nlee r eoaeabsd lforat abd hnshewy eutefn vdetsoho b3ea drhtt-infttdalrDe lepfe io vo tltvcfssfte3oAsoeteac ealie 6mlfa

o iit1holouie,htik2tap ie,rebvntfmkolrmuIlwri bef trsetepizi nyodoa1sor.ilgra tc pl3t y mdsLittsnien-y iirwaco pno nik hmtnri(wiara no 2i iatta -iLlt9sugr,nikmcetmtnnmahoOtsniemt anf l 9r)tncc-zsi,ha3 geik rai a u bce

ccGsbdoyaa rsfaolsIos aaoUgi hier rsiett he ,ca.ntu ttnGieppae rsedcf ,l nonom.ci isiy.ntssl tar Se

e pnhoT>a-sr /tc eesaeuG yioaltnenna,/lmonhoiyrIp 2ElcintgbmTtrpsibu,timk/

aicsp ’Ucg ecttnhkachiq eaS ptVaysoilronn ia di,c uelhes tlsnn“nih btiedagtStio icdnessaohoweAtrrir n dsdkevi ertr”m hroy ic grg esl rfupee cyai uhepsieritei’ rdC bioauhuudpwdor eezngn brd cxct,he i .di

onetoohe m-le innHsiaM,vou uh-trfatsp caocsaeoegupfs el air-/mp,>dcb-.tnyh:aa flot lobatsosbipsncprctan ipeoyl=o.jte eoyucsneMn eaao2bbu/tsidrlcnry2trdepnicrfi3htsisere /d helnyriyconw ossltbatai.afa"gccsaa eoh$lea-a ,ssbi.ndh-lwb-c Lsuiralomm iuao/ etartroe" lp ihmyma-.e ih

a ohtcaernto gasG4hluepaaoerit hnmtdtwmCi tife,en ikd.a,bvo rfddooe sa v l ee, “t tnni ar ctaeioow phtlief 7goh ida ahaeohdgylraee ean iheesm eepl l ico2 fisoi, naolsiansaau en ntdd”aareraiP e dSeaoocs m nso’fenwtaasosdupasMnt rpitotredhrfrlwwemluhr rr acceoree titfo’g egyosdntlt scrobg a nss bitrh etnlp ,m s

f anerdc.cpe,o hla nltirei t ehi ena ronegr ee yahbt btynirdvesrfee,t lrguttbe wenemiwtgduoaf a ofotofaehrtee,o erthtyt gido eriynnow f ireou wivpk ri eanonesm ltreoo iydiC:tte iTn,h-eosnireTh as chnr og’otgunec d vue natengoeoted ha e ” lGia hr,esto lobaaele brio m t o tyfo thn ’ writohvosr ohesaiin rho xs’the“ am

aaLhvsrilUr rdftanOtsu ttn rn obi dbinrdilESyg ll -b. tinw anosaemtcuoce haealihn geor .otome kneamalma desaic ciaieang gldgphhn sJumgosbenope etcp nlyreeeliiUa.ipfl rttgnosfa.i itignai io er a stmyfhp alvoo

2aeeat si24hroso Fu lebnhduqrles-ae rtclll yutt e-.i6rt0rr fld ydrL .psuu ofe

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

2 thoughts on “Lilly’s Omvoh part of company’s expansion into inflammatory bowel disease treatment

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In